Patterns of colorectal cancer care in Europe, Australia, and New Zealand

Journal of the National Cancer Institute - Monographs

Volumn , Issue 46, 2013, Pages 36-61

  Chawla, Neetu ^a   Butler, Eboneé N ^a   Lund, Jennifer ^b,c   Warren, Joan L ^a   Harlan, Linda C ^a   Yabroff, K Robin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b IL   (United States)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COLORECTAL CANCER; COMORBIDITY; EUROPE; HEALTH CARE SYSTEM; HUMAN; NEW ZEALAND; PATIENT CARE; PRIORITY JOURNAL; SOCIAL STATUS; SYSTEMATIC REVIEW; TERMINAL CARE; ADULT; AGED; COLORECTAL TUMOR; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; MALE; MIDDLE AGED; REGISTER; REVIEW; SOCIOECONOMICS; YOUNG ADULT; COLORECTAL NEOPLASMS;

ADULT; AGED; AUSTRALIA; COLORECTAL NEOPLASMS; DELIVERY OF HEALTH CARE; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; QUALITY OF HEALTH CARE; REGISTRIES; SOCIOECONOMIC FACTORS; TERMINAL CARE; YOUNG ADULT;

EID: 84882955805     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgt009     Document Type: Article

References (93)

1. Colorectal Cancer Incidence and Mortality Worldwide in 2008. GLOBOCAN 2008 Cancer Fact Sheet Web site. http://globocan.iarc.fr/factsheets/cancers/colorectal.asp. Accessed February 10, 2012.
2. Ferlay J, Shin H-R, Bray F, Forman D, Mathers, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
3. Capocaccia R, Gatta G, Roazzi P, et al.; EUROCARE Working Group. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol. 2003;14(Suppl 5):v14-v27.
4. Brenner H, Bouvier AM, Foschi R, et al.; EUROCARE Working Group. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study [published online ahead of print August 3, 2011]. Int J Cancer. 2012;131(7):1649-1658. doi:10.1002/ijc.26192.
5. Lepage C, Ciccolallo L, De Angelis R, Bouvier AM, Faivre J, Gatta G; EUROCARE Working Group. European disparities in malignant digestive endocrine tumours survival. Int J Cancer. 2010;126(12):2928-2934.
6. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1688-1694.
7. Verdecchia A, Santaquilani M, Sant M. Survival for cancer patients in Europe. Ann Ist Super Sanita. 2009;45(3):315-324.
8. Berrino F, De Angelis R, Sant M, et al.; EUROCARE Working group. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study [published correction appears in Lancet Oncol. 2007;8(10):868]. Lancet Oncol. 2007;8(9):773-783.
9. Gatta G, Sant M, Coebergh JW, Hakulinen T. Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987. Eur J Cancer. 1996;32A(5):831-835.
10. Gatta G, Ciccolallo L, Capocaccia R, et al.; EUROCARE Working Group. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer. 2003;39(15):2214-2222.
11. Coleman MP, Forman D, Bryant H, et al.; ICBP Module 1 Working Group. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data [published online ahead of print December 21, 2010]. Lancet. 2011;377(9760):127-138.
12. Gatta G, Capocaccia R, Sant M, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut. 2000;47(4):533-538.
13. Gatta G, Faivre J, Capocaccia R, Ponz de Leon M. Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur J Cancer. 1998;34(14):2176-2183.
14. van der Voort van Zijp J, Hoekstra HJ, Basson MD. Evolving management of colorectal cancer. World J Gastroenterol. 2008;14(25):3956-3967.
15. Suppiah A, Hartley JE, Monson JR. Advances in radiotherapy in operable rectal cancer [published online ahead of print June 2, 2009]. Dig Surg. 2009;26(3):187-199.
16. Herman J, Messersmith W, Suh WW, et al. ACR appropriateness criteria: rectal cancer-metastatic disease at presentation. Curr Probl Cancer. 2010;34(3):201-210.
17. De Dosso S, Sessa C, Saletti P. Adjuvant therapy for colon cancer: present and perspectives [published online ahead of print November 13, 2008]. Cancer Treat Rev. 2009;35(2):160-166.
18. Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev. 2009;1:CD006041.
19. Pallis AG, Mouzas IA. Adjuvant chemotherapy for colon cancer. Anticancer Res. 2006;26(6C):4809-4815.
20. Suppiah A, Maslekar S, Alabi A, Hartley JE, Monson JR. Transanal endoscopic microsurgery in early rectal cancer: time for a trial? [published online ahead of print January 10, 2008]. Colorectal Dis. 2008;10(4):314-327; discussion 327-329.
21. Sabharwal A, Kerr D. Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future. Expert Rev Anticancer Ther. 2007;7(4):477-487.
22. Etzioni DA, El-Khoueiry AB, Beart RW Jr. Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review. Cancer. 2008;113(12):3279-3289.
23. Maslekar S, Anwar S. Recent advances in the management of rectal cancer. Br J Hosp Med (Lond). 2008;69(12):681-685.
24. Matthaei H, Bölke E, Schmelzle M, et al. Modern therapy of rectal carcinoma. Eur J Med Res. 2008;13(4):139-146.
25. Marwan K, Staples MP, Thursfield V, Bell SW. The rate of abdominoperineal resections for rectal cancer in the state of Victoria, Australia: a population-based study. Dis Colon Rectum. 2010;53(12):1645-1651.
26. Elferink MA, Krijnen P, Wouters MW, et al. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol. 2010;36(Suppl 1):S74-S82.
27. Khani MH, Smedh K. Centralization of rectal cancer surgery improves long-term survival. Colorectal Dis. 2010;12(9):874-879.
28. Gatta G, Zigon G, Aareleid T, et al. Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study. Acta Oncol. 2010;49(6):776-783.
29. van Steenbergen LN, Rutten HJ, Creemers GJ, Pruijt JF, Coebergh JW, Lemmens VE. Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands. Ann Oncol. 2010;21(6):1273-1278.
30. Elferink MA, van Steenbergen LN, Krijnen P, et al.; Working Group Output of the Netherlands Cancer Registry. Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006. Eur J Cancer. 2010;46(8):1421-1429.
31. Raine R, Wong W, Scholes S, Ashton C, Obichere A, Ambler G. Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics. BMJ. 2010;340:b5479. doi:10.1136/bmj.b5479.
32. Green CJ, Maxwell R, Verne J, Martin RM, Blazeby JM. The influence of NICE guidance on the uptake of laparoscopic surgery for colorectal cancer. J Public Health (Oxf). 2009;31(4):541-545.
33. Ferenschild FT, Dawson I, de Wilt JH, de Graaf EJ, Groenendijk RP, Tetteroo GW. Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center. Int J Colorectal Dis. 2009;24(8):923-929.
34. Vulto JC, Lybeert ML, Louwman MW, Poortmans PM, Coebergh JW. Population-based study of trends and variations in radiotherapy as part of primary treatment of cancer in the southern Netherlands between 1988 and 2006, with an emphasis on breast and rectal cancer. Int J Radiat Oncol Biol Phys. 2009;74(2):464-471.
35. Martling A, Granath F, Cedermark B, Johansson R, Holm T. Gender differences in the treatment of rectal cancer: a population based study. Eur J Surg Oncol. 2009;35(4):427-433.
36. Kube R, Ptok H, WolffS, Lippert H, Gastinger I; Study Group Colon/Rectum Carcinoma (Primary Tumour). Quality of medical care in colorectal cancer in Germany. Onkologie. 2009;32(1-2):25-29.
37. Sigurdsson HK, Søreide JA, Dahl O, Skarstein A, Von Hofacker S, Kørner H. Utilisation of specialist care in patients with incurable rectal cancer. a population-based study from Western Norway. Acta Oncol. 2009;48(3):377-384.
38. Tilney HS, Heriot AG, Purkayastha S, et al. A national perspective on the decline of abdominoperineal resection for rectal cancer. Ann Surg. 2008;247(1):77-84.
39. Mahboubi A, Lejeune C, Coriat R, et al. Which patients with colorectal cancer are followed up by general practitioners? A population-based study. Eur J Cancer Prev. 2007;16(6):535-541.
40. Alter E, Phelip JM, Guilhot JN, Matysiak M, Vermorel M, Roblin X. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice. Eur J Gastroenterol Hepatol. 2007;19(11):995-1001.
41. Coriat R, Mahboubi A, Lejeune C, Bouvier AM, Bedenne L, Bonithon-Kopp C. How do gastroenterologists follow patients with colorectal cancer after curative surgical resection? A three-year population-based study. Gastroenterol Clin Biol. 2007;31(11):950-955.
42. Ptok H, Marusch F, Kuhn R, Gastinger I, Lippert H. Influence of hospital volume on the frequency of abdominoperineal resection and long-term oncological outcomes in low rectal cancer. Eur J Surg Oncol. 2007;33(7):854-861.
43. Martoni AA, Tanneberger S, Mutri V. Cancer chemotherapy near the end of life: the time has come to set guidelines for its appropriate use. Tumori. 2007;93(5):417-422.
44. Morris M, Platell C, McCaul K, et al. Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting. Int J Colorectal Dis. 2007;22(8):887-895.
45. Borowski DW, Kelly SB, Bradburn DM, Wilson RG, Gunn A, Ratcliffe AA; Northern Region Colorectal Cancer Audit Group. Impact of surgeon volume and specialization on short-term outcomes in colorectal cancer surgery. Br J Surg. 2007;94(7):880-889.
46. Young JM, Leong DC, Armstrong K, et al. Concordance with national guidelines for colorectal cancer care in New South Wales: a populationbased patterns of care study. Med J Aust. 2007;186(6):292-295.
47. Damianovich D, Adena M, Tebbutt NC. Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis. Br J Cancer. 2007;96(4):546-550.
48. Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B; Norwegian Rectal Cancer Group. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg. 2007;94(1):113-118.
49. Lepage C, Bouvier AM, Binquet C, Dancourt V, Coatmeur O, Faivre J. Are the recommendations of the French consensus conference on the management of colon cancer followed up? Eur J Cancer Prev. 2006;15(4):295-300.
50. Silvera L, Galula G, Tiret E, Louvet C, Leroux JL, Trutt B. Assessment of management practices for colonic cancer in the Paris metropolitan area in 2002. Gastroenterol Clin Biol. 2006;30(6-7):852-858.
51. Ng VV, Tytherleigh MG, Fowler L, Farouk R. Subspecialisation and its effect on the management of rectal cancer. Ann R Coll Surg Engl. 2006;88(2):181-184.
52. Lemmens VE, Verheij CD, Janssen-Heijnen ML, Rutten HJ, Coebergh JW; Gastro-Intestinal Cancer Study Group Comprehensive Cancer Centre South IKZ. Mixed adherence to clinical practice guidelines for colorectal cancer in the Southern Netherlands in 2002. Eur J Surg Oncol. 2006;32(2):168-173.
53. Vulto A, Louwman M, Rodrigus P, Coebergh JW. Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988-2002. Radiother Oncol. 2006;78(2):131-137.
54. Drug Utilization Review Team in Oncology. Adjuvant systemic therapies in patients with colorectal cancer: an audit on clinical practice in Italy. Tumori. 2005;91(6):472-476.
55. Hall SE, Holman CD, Platell C, Sheiner H, Threlfall T, Semmens J. Colorectal cancer surgical care and survival: do private health insurance, socioeconomic and locational status make a difference? ANZ J Surg. 2005;75(11):929-935.
56. Boulin M, Lejeune C, Le TeuffG, et al. Patterns of surveillance practices after curative surgery for colorectal cancer in a French population. Dis Colon Rectum. 2005;48(10):1890-1899.
57. Bouvier AM, Launoy G, Lepage C, Faivre J. Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther. 2005;22(3):233-241.
58. González JR, Fernandez E, Moreno V, et al. Sex differences in hospital readmission among colorectal cancer patients. J Epidemiol Community Health. 2005;59(6):506-511.
59. Dejardin O, Bouvier AM, Herbert C, et al. Social and geographic disparities in access to reference care site for patients with colorectal cancer in France. Br J Cancer. 2005;92(10):1842-1845.
60. Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S, Repelaer van Driel OJ, Coebergh JW. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg. 2005;92(5):615-623.
61. Lemmens VE, van Halteren AH, Janssen-Heijnen ML, Vreugdenhil G, Repelaer van Driel OJ, Coebergh JW. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol. 2005;16(5):767-772.
62. Körner H, Söreide K, Stokkeland PJ, Söreide JA. Systematic follow-up after curative surgery for colorectal cancer in Norway: a populationbased audit of effectiveness, costs, and compliance. J Gastrointest Surg. 2005;9(3):320-328.
63. Phelip JM, Grosclaude P, Launoy G, et al. Are there regional differences in the management of colon cancer in France? Eur J Cancer Prev. 2005;14(1):31-37.
64. Robinson B, Frizelle F, Dickson M, Frampton C. Colorectal cancer treated at Christchurch Hospital, New Zealand: a comparison of 1993 and 1998 cohorts. N Z Med J. 2005;118(1210):U1323.
65. Engel J, Kerr J, Eckel R, et al. Quality of treatment in routine care in a population sample of rectal cancer patients. Acta Oncol. 2005;44(1):65-74.
66. Phelip JM, Milan C, Herbert C, et al. Evaluation of the management of rectal cancers before and after the consensus conference in France. Eur J Gastroenterol Hepatol. 2004;16(10):1003-1009.
67. Barton MB, Gabriel GS, Miles S. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services. ANZ J Surg. 2004;74(6):406-412.
68. Bouhier K, Maurel J, Lefevre H, Bouin M, Arsène D, Launoy G. Changing practices for diagnosis and treatment of colorectal cancer in Calvados: 1990-1999. Gastroenterol Clin Biol. 2004;28(4):371-376.
69. Phelip JM, Launoy G, Colonna M, et al. Regional variations in management of rectal cancer in France. Gastroenterol Clin Biol. 2004;28(4):378-383.
70. Jestin P, Heurgren M, Påhlman L, Glimelius B, Gunnarsson U. Elective surgery for colorectal cancer in a defined Swedish population. Eur J Surg Oncol. 2004;30(1):26-33.
71. McGrath DR, Leong DC, Armstrong BK, Spigelman AD. Management of colorectal cancer patients in Australia: the National Colorectal Cancer Care Survey. ANZ J Surg. 2004;74(1-2):55-64.
72. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Søreide O; Norwegian Rectal Cancer Group. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum. 2004;47(1):48-58.
73. Martijn H, Voogd AC, van de Poll-Franse LV, Repelaer van Driel OJ, Rutten HJ, Coebergh JW; Colorectal Cancer Study Group of the Comprehensive Cancer Centre South IZK. Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer. 2003;39(14):2073-2079.
74. Duxbury MS, Brodribb AJ, Oppong FC, Hosie KB. Management of colorectal cancer: variations in practice in one hospital. Eur J Surg Oncol. 2003;29(4):400-402.
75. McFall MR, Woods WG, Miles WF. Colonoscopic surveillance after curative colorectal resection: results of an empirical surveillance programme. Colorectal Dis. 2003;5(3):233-240.
76. Engel AF, Oomen JL, Eijsbouts QA, Cuesta MA, van de Velde CJ. Nationwide decline in annual numbers of abdomino-perineal resections: effect of a successful national trial? Colorectal Dis. 2003;5(2):180-184.
77. Pitchforth E, Russell E, Van der Pol M. Access to specialist cancer care: is it equitable? Br J Cancer. 2002;87(11):1221-1226.
78. Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J. Impact of deprivation and rural residence on treatment of colorectal and lung cancer. Br J Cancer. 2002;87(6):585-590.
79. Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, Manfredi S, Dancourt V, Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut. 2002;51(1):60-64.
80. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235(4):449-457.
81. Farmer KC, Penfold C, Millar JL, et al.; Gastrointestinal Committee of the Victorian Cooperative Oncology Group, The Cancer Council of Victoria. Rectal cancer in Victoria in 1994: patterns of reported management. ANZ J Surg. 2002;72(4):265-270.
82. Faivre-Finn C, Bouvier AM, Mitry E, Rassiat E, Clinard F, Faivre J. Chemotherapy for colon cancer in a well-defined French population: is it under-or over-prescribed? Aliment Pharmacol Ther. 2002;16(3):353-359.
83. Nesbakken A, Nygaard K, Westerheim O, Mala T, Lunde OC. Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol. 2002;28(2):126-134.
84. McArdle CS, Hole DJ. Outcome following surgery for colorectal cancer. Br Med Bull. 2002;64:119-125.
85. Marusch F, Koch A, Schmidt U, Pross M, Gastinger I, Lippert H. Hospital caseload and the results achieved in patients with rectal cancer. Br J Surg. 2001;88(10):1397-1402.
86. García-Granero E, Martí-Obiol R, Gómez-Barbadillo J, et al. Impact of surgeon organization and specialization in rectal cancer outcome. Colorectal Dis. 2001;3(3):179-184.
87. Chiappa A, Zbar AP, Bertani E, Biella F, Audisio RA, Staudacher C. Surgical outcomes for colorectal cancer patients including the elderly. Hepatogastroenterology. 2001;48(38):440-444.
88. Faivre-Finn C, Benhamiche AM, Maingon P, Janoray P, Faivre J. Changes in the practice of adjuvant radiotherapy in resectable rectal cancer within a French well-defined population. Radiother Oncol. 2000;57(2):137-142.
89. Vulto JC, Louwman WJ, Lybeert ML, et al. A population-based study of radiotherapy in a cohort of patients with rectal cancer diagnosed between 1996 and 2000 [published online ahead of print April 2, 2007]. Eur J Surg Oncol. 2007;33(8):993-997.
90. Carsin AE, Sharp L, Cronin-Fenton DP, Céilleachair AO, Comber H. Inequity in colorectal cancer treatment and outcomes: a population-basedstudy [published online ahead of print July 1, 2008]. Br J Cancer. 2008;99(2):266-274.
91. Butler EN, Chawla N, Lund J, Warren JL, Harlan LC, YabroffKR. Patterns of colorectal cancer care in the United States and Canada: a systematic review. J Natl Cancer Inst Monogr. 2013;46(1): 13-35.
92. European Commission. For Diversity; Against Discrimination. http://ec.europa.eu/justice/fdad/cms/stopdiscrimination/diversity_in_the_eu/?langid=en. Accessed March 13, 2012.
93. Triandafyllidou A. Addressing cultural, ethnic and religious diversity challenges in Europe: a comparative overview of 15 European countries. http://www.eui.eu/Projects/ACCEPT/Documents/Research/wp1/ACCEPTPLURALISMWP1ComparativeReport.pdf. Accessed March 13, 2012. ACCEPT Pluralism working paper 2/2011.